Online Pain Coping Skills Training for Joint Pain in Breast Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if an online program can help women with joint pain, a common side effect of certain breast cancer medications, feel better and manage their pain more effectively. Participants will either receive education about their medication and joint pain or receive that education plus access to an online pain coping skills training program. The trial will compare the two groups to see if the online program improves pain, emotional well-being, and medication adherence. Women who have completed primary treatment for stage I-III breast cancer, are on aromatase inhibitor therapy, and experience frequent joint pain may be suitable for this study. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to potentially groundbreaking treatment advancements.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. However, if you are taking pain relievers, you need to be on a stable dose for at least 14 days before joining the study and should not plan to increase the dose during the study. You can discuss any changes with your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that online training for coping with pain has been well-received. For instance, one study found that participants experienced less pain and required fewer pain medications. They also gained confidence in managing their pain and adopted better coping strategies. This suggests the training is safe and could benefit those experiencing joint pain from AI medications used to treat breast cancer. No major negative side effects have been reported from the training itself, indicating it is likely a safe option for those seeking better pain management.12345
Why are researchers excited about this trial?
Researchers are excited about the Online Pain Coping Skills Training for joint pain in breast cancer survivors because it offers a novel, digital approach to managing pain without medication. Unlike standard treatments that often rely on pain medications or physical therapy, this online program empowers patients with cognitive and behavioral skills to manage their pain effectively. The program's interactive nature and convenience allow participants to access it from home, making it accessible even for those with busy schedules or limited mobility. By potentially reducing pain-related interference with daily activities, this method represents a promising shift towards more patient-centered and self-managed care.
What evidence suggests that this trial's treatments could be effective for joint pain in breast cancer survivors?
This trial will compare two approaches for managing joint pain in breast cancer survivors taking aromatase inhibitors (AI). One group will receive an educational booklet about AI side effects and management strategies. Another group will receive both the educational booklet and access to an online pain coping skills training program. Research has shown that online training for pain management can help breast cancer survivors who experience joint pain from AIs. Specifically, studies found that participants who learned these skills reported less pain and improved pain management. They also felt more confident in managing their pain and required fewer pain medications. Additionally, these programs enhanced their emotional well-being and overall quality of life. Early results suggest that learning these skills online could effectively manage AI-related pain and improve daily life.23467
Are You a Good Fit for This Trial?
This trial is for postmenopausal women over 18 with Stage I-III hormone receptor positive breast cancer, who've finished primary treatment and are on stable AI therapy experiencing joint pain. They must be English-speaking, able to use digital devices for online training, and likely to complete the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive education about AIs and arthralgia, with or without access to an online pain coping skills training program, completed over 8 to 10 weeks.
Follow-up 1
Participants' medication adherence is monitored using electronic pill bottles.
Follow-up 2
Participants are monitored for changes in menopause-specific quality of life.
Follow-up 3
Participants are monitored for changes in pain, emotional distress, sleep disturbance, and medication adherence.
What Are the Treatments Tested in This Trial?
Interventions
- Education
- Online Pain Coping Skills Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Duke University
Collaborator
National Cancer Institute (NCI)
Collaborator